Obaid ur Rehman — Contributing Journalist, South & Central Asia | About the author →
India was supposed to be the easy answer.
For years, global investors looking to reduce exposure to China have treated India as one of the most important alternatives: large, young, democratic, strategically aligned with Washington and increasingly central to electronics, pharmaceuticals, industrial supply chains and private-market allocation.
That story is still intact. But it is no longer simple.
The latest U.S.-India trade dispute shows how quickly a strategic partnership can turn into a portfolio risk. What began as a fight over tariffs and market access has expanded into a broader negotiation over energy sourcing, Russian oil, U.S. agriculture, industrial policy, defense, technology and the future of supply-chain alignment.
For asset owners, that matters. India is not just another emerging market. It is one of the world's largest and fastest-growing major economies, a central node in China-plus-one manufacturing strategies, a rising allocation target for global private capital and an increasingly important market for sovereign wealth funds, pensions, insurers and long-horizon investors.
The question is no longer whether India matters. It is whether investors are pricing the new political risk correctly.
The deal that became a stress test
The U.S. and India entered 2025 with an ambitious goal: to deepen commercial ties and push bilateral trade toward $500 billion by 2030. Washington viewed India as a crucial counterweight to China in the Indo-Pacific. New Delhi wanted investment, technology, energy security and manufacturing scale.
Then trade politics intervened.
President Donald Trump's second administration made bilateral trade deficits a central measure of economic fairness. India, which sells far more goods to the United States than it buys from it, quickly became exposed. Washington objected to India's tariff barriers, non-tariff restrictions and limited market access for American agriculture, industrial products and technology.
India's position was different. New Delhi argued that opening sensitive sectors too quickly, especially agriculture, could create severe domestic backlash. U.S. products such as corn, soybeans, ethanol, distillers' grains and other farm goods sit inside one of the most politically sensitive areas of Indian economic policy. Any concession to Washington would be judged not only by trade negotiators, but by farmers, opposition parties, state governments and the BJP's own political base.
The dispute escalated further when Washington linked tariff pressure to India's purchases of Russian oil. That moved the conflict beyond trade into geopolitics.
India has defended its energy purchases as a matter of strategic autonomy and economic necessity. The United States has treated them as part of a wider sanctions and alignment problem. For investors, that is the central lesson: in the new trade regime, the tariff line is no longer clean. A country's access to U.S. markets can become tied to energy sourcing, security policy, defense alignment, technology controls or domestic political symbolism.
In early 2026, the two sides moved toward a partial truce. The United States agreed to lower the tariff rate on Indian goods to 18% and to remove the punitive duty linked to Russian oil purchases. India signaled willingness to reduce tariffs on a range of U.S. industrial, agricultural and technology products.
But the broader agreement remains more framework than final settlement. The unresolved questions are the ones that matter most for investors: how much tariff relief Indian exporters ultimately receive, how far India opens agricultural markets, whether Russian oil purchases decline permanently, how supply-chain rules are written and whether future political shocks can reopen the dispute.
Why universal owners should care
The dispute sits at the intersection of four major portfolio questions: supply-chain diversification, tariff risk, energy security and emerging-market flows.
For a large asset owner, this is not simply a story about Indian exporters or U.S. importers. It affects country allocation, currency expectations, sector valuations, industrial policy, infrastructure demand, private-market underwriting and the credibility of India as a long-term China-plus-one platform.
The most important point is also the simplest: political alignment does not eliminate policy risk.
India may be strategically important to the United States. It may be a democratic counterweight to China. It may remain one of the world's most important growth markets. But none of that prevents Washington from using tariffs as leverage, or New Delhi from resisting concessions that threaten domestic political stability.
That is the new investment environment.
1. The China-plus-one trade is not automatic
India has been one of the largest beneficiaries of the global effort to diversify manufacturing away from China. Electronics, pharmaceuticals, chemicals, auto components, aircraft parts and industrial supply chains have all become part of the India allocation story.
Apple's expansion in India is the most visible example, but the broader shift is much larger. Global companies want redundancy. Governments want resilient supply chains. Investors want exposure to the next large manufacturing platform.
A favorable U.S.-India trade deal would reinforce that story. A prolonged tariff dispute would do the opposite. If Indian exporters face higher U.S. duties than competitors in Vietnam, Mexico, Southeast Asia or other aligned markets, India's competitive edge narrows.
That matters for asset owners because country allocation is not based on growth alone. It depends on the durability of policy access, the reliability of trade routes and the confidence that capital invested today will not be stranded by tomorrow's politics.
2. Tariffs become margin compression
Tariffs are often discussed as political instruments. For investors, they are also a margin problem.
If Indian exporters face higher duties, someone must absorb the cost. Exporters can cut margins. U.S. importers can accept lower profitability. Consumers can pay higher prices. Supply chains can be rerouted.
The exposed sectors include textiles and apparel, leather and footwear, gems and diamonds, organic chemicals, plastics and rubber, machinery, steel, auto components, aircraft parts and pharmaceuticals. Labor-intensive exporters are especially vulnerable because they often compete on cost and have limited ability to absorb sudden tariff shocks.
Pharmaceuticals deserve special attention. India is deeply embedded in the U.S. generic drug supply chain. A tariff regime that disrupts generic supply could create pressure inside the U.S. healthcare system, while any exemptions could create winners and losers inside Indian equities.
3. Energy is the hidden tariff
The oil issue is the part of the dispute investors should not ignore.
India is one of the world's largest oil importers and depends heavily on imported crude. Since the invasion of Ukraine, discounted Russian oil has become an important part of India's energy mix. Russia has been India's largest single crude supplier, though not a majority supplier.
If India reduces Russian purchases under U.S. pressure, its energy economics could change. That could affect India's current account, inflation expectations, refinery margins and the rupee. A higher import bill would put pressure on macro stability. A weaker currency would affect foreign investor returns.
For sovereign investors, this is doubly important. Gulf funds such as ADIA, Mubadala, Qatar Investment Authority and Saudi Arabia's PIF have strategic reasons to watch India closely, both as investors and as representatives of major energy-producing economies. Singapore-linked investors such as GIC and Temasek also have deep exposure to Asia's supply-chain and growth dynamics.
4. India now carries a new risk premium
The deeper warning is that U.S.-India relations are becoming more transactional.
Strategic alignment still matters. Washington still wants India as a counterweight to China. India still wants U.S. technology, energy, market access and defense cooperation. But the relationship is increasingly being negotiated issue by issue, demand by demand, concession by concession.
That creates a new risk premium. A dispute over agriculture can affect exporters. A dispute over Russian oil can affect tariffs. A dispute over visas can affect technology services. A dispute over pharmaceuticals can affect healthcare supply chains.
For asset owners, that means India should remain a core long-term market, but not a frictionless one. The investment case needs to include domestic politics, U.S. election cycles, sanctions policy, energy sourcing, agricultural sensitivity, currency pressure and the possibility that unrelated issues become bundled into future negotiations.
What investors should watch next
The first signal is whether the interim agreement becomes a durable trade deal. A reduced tariff rate is positive, but 18% is still a meaningful friction compared with the low-tariff world investors were accustomed to.
The second signal is agriculture. This remains one of the hardest parts of the negotiation. Investors should watch whether India uses phased access, tariff-rate quotas, sanitary rules or tightly limited product categories as a compromise.
The third signal is energy sourcing. If India reduces Russian crude and increases purchases from the United States, the Gulf, or other suppliers, investors should track oil prices, refinery margins, the rupee, the current-account deficit and inflation expectations.
The fourth signal is spillover. Trade tensions could bleed into visas, defense procurement, technology controls, steel, pharmaceuticals, critical minerals or third-country oil flows.
The portfolio conclusion
India remains one of the most important long-term markets in the world. That has not changed.
What has changed is the assumption that strategic importance protects investors from policy volatility.
The U.S.-India relationship is now too important to ignore, but too transactional to treat as risk-free. For universal owners, the lesson is clear: India may still be the China hedge. But it is also becoming its own geopolitical, energy and tariff risk.
Long-horizon investors do not need to abandon the India thesis. They need to underwrite it more seriously.
Researched and edited by the UAO editorial desk. Obaid ur Rehman is a contributing journalist at Universal Asset Owners covering geopolitics and South & Central Asian capital dynamics.